help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auernhammer, C. J.
Right arrow Articles by Melmed, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auernhammer, C. J.
Right arrow Articles by Melmed, S.
Endocrine Reviews 21 (3): 313-345
Copyright © 2000 by The Endocrine Society

Leukemia-Inhibitory Factor—Neuroimmune Modulator of Endocrine Function1

C. J. Auernhammer2 and S. Melmed

Academic Affairs, Cedars-Sinai Research Institute, University of California Los Angeles School of Medicine, Los Angeles, California 90048

Leukemia-inhibitory factor (LIF) is a pleiotropic cytokine expressed by multiple tissue types. The LIF receptor shares a common gp130 receptor subunit with the IL-6 cytokine superfamily. LIF signaling is mediated mainly by JAK-STAT (janus-kinase-signal transducer and activator of transcription) pathways and is abrogated by the SOCS (suppressor-of cytokine signaling) and PIAS (protein inhibitors of activated STAT) proteins. In addition to classic hematopoietic and neuronal actions, LIF plays a critical role in several endocrine functions including the utero-placental unit, the hypothalamo-pituitary-adrenal axis, bone cell metabolism, energy homeostasis, and hormonally responsive tumors. This paper reviews recent advances in our understanding of molecular mechanisms regulating LIF expression and action and also provides a systemic overview of LIF-mediated endocrine regulation. Local and systemic LIF serve to integrate multiple developmental and functional cell signals, culminating in maintaining appropriate hormonal and metabolic homeostasis. LIF thus functions as a critical molecular interface between the neuroimmune and endocrine systems.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. J. Grossberg, J. M. Scarlett, X. Zhu, D. D. Bowe, A. K. Batra, T. P. Braun, and D. L. Marks
Arcuate Nucleus Proopiomelanocortin Neurons Mediate the Acute Anorectic Actions of Leukemia Inhibitory Factor via gp130
Endocrinology, February 1, 2010; 151(2): 606 - 616.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
L Mohamet, J K Heath, and S J Kimber
Determining the LIF-sensitive period for implantation using a LIF-receptor antagonist
Reproduction, November 1, 2009; 138(5): 827 - 836.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
G. Song, M C. Satterfield, J. Kim, F. W Bazer, and T. E Spencer
Progesterone and interferon tau regulate leukemia inhibitory factor receptor and IL6ST in the ovine uterus during early pregnancy
Reproduction, March 1, 2009; 137(3): 553 - 565.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
I. V Mikhaylova, T. Jaaskelainen, J. Jaaskelainen, J. J Palvimo, and R. Voutilainen
Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells
J. Endocrinol., December 1, 2008; 199(3): 435 - 444.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Labeur, D. Refojo, B. Wolfel, J. Stalla, V. Vargas, M. Theodoropoulou, M. Buchfelder, M. Paez-Pereda, E. Arzt, and G. K Stalla
Interferon-{gamma} inhibits cellular proliferation and ACTH production in corticotroph tumor cells through a novel janus kinases-signal transducer and activator of transcription 1/nuclear factor-kappa B inhibitory signaling pathway
J. Endocrinol., November 1, 2008; 199(2): 177 - 189.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
S. Yamanaka
Pluripotency and nuclear reprogramming
Phil Trans R Soc B, June 27, 2008; 363(1500): 2079 - 2087.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Endoh, T. A. Endo, T. Endoh, Y.-i. Fujimura, O. Ohara, T. Toyoda, A. P. Otte, M. Okano, N. Brockdorff, M. Vidal, et al.
Polycomb group proteins Ring1A/B are functionally linked to the core transcriptional regulatory circuitry to maintain ES cell identity
Development, April 15, 2008; 135(8): 1513 - 1524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. H. Damon
TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C306 - C312.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Wanggren, P.G. Lalitkumar, F. Hambiliki, B. Stabi, K. Gemzell-Danielsson, and A. Stavreus-Evers
Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo
Mol. Hum. Reprod., June 1, 2007; 13(6): 391 - 397.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J.-O. Jansson, S. Moverare-Skrtic, A. Berndtsson, I. Wernstedt, H. Carlsten, and C. Ohlsson
Leukemia inhibitory factor reduces body fat mass in ovariectomized mice
Eur. J. Endocrinol., February 1, 2006; 154(2): 349 - 354.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Kariagina, S. Zonis, M. Afkhami, D. Romanenko, and V. Chesnokova
Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E857 - E863.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. D. Catalano, M. H. Johnson, E. A. Campbell, D. S. Charnock-Jones, S. K. Smith, and A. M. Sharkey
Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception
PNAS, June 14, 2005; 102(24): 8585 - 8590.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E.-J. Kim, J.-I. Park, and B. D. Nelkin
IFI16 Is an Essential Mediator of Growth Inhibition, but Not Differentiation, Induced by the Leukemia Inhibitory Factor/JAK/STAT Pathway in Medullary Thyroid Carcinoma Cells
J. Biol. Chem., February 11, 2005; 280(6): 4913 - 4920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
I. Nozaki, J. G. Lunz III, S. Specht, J.-I. Park, A. S. Giraud, N. Murase, and A. J. Demetris
Regulation and Function of Trefoil Factor Family 3 Expression in the Biliary Tree
Am. J. Pathol., December 1, 2004; 165(6): 1907 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. R. A. Sherwin, T. C. Freeman, R. J. Stephens, S. Kimber, A. G. Smith, I. Chambers, S. K. Smith, and A. M. Sharkey
Identification of Genes Regulated by Leukemia-Inhibitory Factor in the Mouse Uterus at the Time of Implantation
Mol. Endocrinol., September 1, 2004; 18(9): 2185 - 2195.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Suzuki, L. S. Wright, P. Marwah, H. A. Lardy, and C. N. Svendsen
Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex
PNAS, March 2, 2004; 101(9): 3202 - 3207.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. A. Abbud, R. Kelleher, and S. Melmed
Cell-Specific Pituitary Gene Expression Profiles after Treatment with Leukemia Inhibitory Factor Reveal Novel Modulators for Proopiomelanocortin Expression
Endocrinology, February 1, 2004; 145(2): 867 - 880.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Vlotides, K. Zitzmann, S. Hengge, D. Engelhardt, G. K. Stalla, and C. J. Auernhammer
Expression of Novel Neurotrophin-1/B-Cell Stimulating Factor-3 (NNT-1/BSF-3) in Murine Pituitary Folliculostellate TtT/GF Cells: Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide-Induced Stimulation of NNT-1/BSF-3 Is Mediated by Protein Kinase A, Protein Kinase C, and Extracellular-Signal-Regulated Kinase1/2 Pathways
Endocrinology, February 1, 2004; 145(2): 716 - 727.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Nightingale, S. Patel, N. Suzuki, R. Buxton, K.-i. Takagi, J. Suzuki, Y. Sumi, A. Imaizumi, R. M. Mason, and Z. Zhang
Oncostatin M, a Cytokine Released by Activated Mononuclear Cells, Induces Epithelial Cell-Myofibroblast Transdifferentiation via Jak/Stat Pathway Activation
J. Am. Soc. Nephrol., January 1, 2004; 15(1): 21 - 32.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Kariagina, D. Romanenko, S.-G. Ren, and V. Chesnokova
Hypothalamic-Pituitary Cytokine Network
Endocrinology, January 1, 2004; 145(1): 104 - 112.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. Fedorcsak and R. Storeng
Effects of Leptin and Leukemia Inhibitory Factor on Preimplantation Development and STAT3 Signaling of Mouse Embryos In Vitro
Biol Reprod, November 1, 2003; 69(5): 1531 - 1538.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Auernhammer, N. B. Isele, F. B. Kopp, G. Spoettl, N. Cengic, M. M. Weber, G. Senaldi, and D. Engelhardt
Novel Neurotrophin-1/B Cell-Stimulating Factor-3 (Cardiotrophin-Like Cytokine) Stimulates Corticotroph Function via a Signal Transducer and Activator of Transcription-Dependent Mechanism Negatively Regulated by Suppressor of Cytokine Signaling-3
Endocrinology, April 1, 2003; 144(4): 1202 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
A. Beishuizen and L. G. Thijs
Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis
Innate Immunity, February 1, 2003; 9(1): 3 - 24.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Ben-Shlomo, I. Miklovsky, S.-G. Ren, W. H. Yong, A. P. Heaney, M. D. Culler, and S. Melmed
Leukemia Inhibitory Factor Regulates Prolactin Secretion in Prolactinoma and Lactotroph Cells
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 858 - 863.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. P. Castro, D. Giacomini, A. C. Nagashima, C. Onofri, M. Graciarena, K. Kobayashi, M. Paez-Pereda, U. Renner, G. K. Stalla, and E. Arzt
Reduced Expression of the Cytokine Transducer gp130 Inhibits Hormone Secretion, Cell Growth, and Tumor Development of Pituitary Lactosomatotrophic GH3 Cells
Endocrinology, February 1, 2003; 144(2): 693 - 700.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J.-I. Park, C. J. Strock, D. W. Ball, and B. D. Nelkin
The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway
Mol. Cell. Biol., January 15, 2003; 23(2): 543 - 554.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Mynard, L. Guignat, J. Devin-Leclerc, X. Bertagna, and M. G. Catelli
Different Mechanisms for Leukemia Inhibitory Factor-Dependent Activation of Two Proopiomelanocortin Promoter Regions
Endocrinology, October 1, 2002; 143(10): 3916 - 3924.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Toniato, X. P. Chen, J. Losman, V. Flati, L. Donahue, and P. Rothman
TRIM8/GERP RING Finger Protein Interacts with SOCS-1
J. Biol. Chem., September 27, 2002; 277(40): 37315 - 37322.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Palmqvist, E. Persson, H. H. Conaway, and U. H. Lerner
IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-{kappa}B Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvariae
J. Immunol., September 15, 2002; 169(6): 3353 - 3362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. E. Spangenburg and F. W. Booth
Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation
Am J Physiol Cell Physiol, July 1, 2002; 283(1): C204 - C211.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Chesnokova and S. Melmed
Minireview: Neuro-Immuno-Endocrine Modulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis by gp130 Signaling Molecules
Endocrinology, May 1, 2002; 143(5): 1571 - 1574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Blanchard, Y. Wang, E. Kinzie, L. Duplomb, A. Godard, and H. Baumann
Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor alpha , and Oncostatin M Receptor beta by Distinct Mechanisms
J. Biol. Chem., December 7, 2001; 276(50): 47038 - 47045.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Bousquet, V. Chesnokova, A. Kariagina, A. Ferrand, and S. Melmed
cAMP Neuropeptide Agonists Induce Pituitary Suppressor of Cytokine Signaling-3: Novel Negative Feedback Mechanism for Corticotroph Cytokine Action
Mol. Endocrinol., November 1, 2001; 15(11): 1880 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-G. Cheng, J. R. Chen, L. Hernandez, W. G. Alvord, and C. L. Stewart
Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation
PNAS, June 28, 2001; (2001) 151180898.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Mauduit, I. Goddard, V. Besset, E. Tabone, C. Rey, F. Gasnier, F. Dacheux, and M. Benahmed
Leukemia Inhibitory Factor Antagonizes Gonadotropin Induced-Testosterone Synthesis in Cultured Porcine Leydig Cells: Sites of Action
Endocrinology, June 1, 2001; 142(6): 2509 - 2520.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. R. Chen, J.-G. Cheng, T. Shatzer, L. Sewell, L. Hernandez, and C. L. Stewart
Leukemia Inhibitory Factor Can Substitute for Nidatory Estrogen and Is Essential to Inducing a Receptive Uterus for Implantation But Is Not Essential for Subsequent Embryogenesis
Endocrinology, December 1, 2000; 141(12): 4365 - 4372.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-G. Cheng, J. R. Chen, L. Hernandez, W. G. Alvord, and C. L. Stewart
Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation
PNAS, July 17, 2001; 98(15): 8680 - 8685.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Chesnokova, A. Kariagina, and S. Melmed
Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1110 - E1118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society